Today's special offer: Access for Free!!!

Novo Nordisk A/S (NVO) | Statement of Financial Position, Liabilities and Stockholders' Equity

See also

ˇ Show More

The statement of financial position provides creditors, investors, and analysts with information on company's resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company's assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

You have visited 10 password protected pages for free. Others contain data covered by .

Sign Up Now to get full access to whole website and cut out all advertisements.

Novo Nordisk A/S, Consolidated Statement of Financial Position, Liabilities and Stockholders' Equity

USD $ in millions, translated from DKK kr

Export to Excel Export to OpenOffice.org
    Dec 31, 2011 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008 Dec 31, 2007
chart Share capital
chart Treasury shares
chart Retained earnings
chart Other reserves
chart Equity
chart Loans
chart Deferred income tax liabilities
chart Retirement benefit obligations
chart Provisions for product returns
chart Provision for legal disputes
chart Other provisions
chart Provisions
chart Non-current liabilities
chart Current debt
chart Trade payables
chart Tax payables
chart Employee costs payable
chart Accruals
chart Taxes and duties payable
chart R&D clinical trials
chart Other payables
chart Other current liabilities
chart Derivative financial instruments
chart Provisions for sales rebates
chart Provisions for product returns
chart Other provisions
chart Provisions for other liabilities
chart Current liabilities
chart Total liabilities
chart Total equity and liabilities
Source: Novo Nordisk A/S, Annual Reports
Item Description The company
Equity Total of all Stockholders' Equity (deficit) items, net of receivables from officers, directors owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). Novo Nordisk A/S's equity declined from 2009 to 2010 and from 2010 to 2011.
Non-current liabilities Total obligations incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle. Novo Nordisk A/S's non-current liabilities declined from 2009 to 2010 but then increased from 2010 to 2011 exceeding 2009 level.
Trade payables Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Novo Nordisk A/S's trade payables increased from 2009 to 2010 and from 2010 to 2011.
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Novo Nordisk A/S's current liabilities increased from 2009 to 2010 and from 2010 to 2011.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Novo Nordisk A/S's total liabilities increased from 2009 to 2010 and from 2010 to 2011.

Top

Stock Analysis on Net (www.stock-analysis-on.net)
Copyright © 2012 EBIT Financial Analyses Center